To circumvent size restrictions of percutaneous heart valves, we designed a novel low-profile valved stent made of polyurethane which fits into a 14-French delivery device ( Fig. 1) . Transfemoral implantation in pulmonary position was evaluated in two sheep. Competent valves with low gradients were seen at the 1-month follow-up (Fig. 2) .
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